Skip to content

Examination of Relevance of Indexes Concerning on Evaluation for Texture, Tightness and Slack of Adault Female's Skin

Examination of Relevance of Indexes Concerning on Evaluation for Texture, Tightness and Slack of Adault Female's Skin - Examination of Relevance of Indexes Concerning on Evaluation for Texture, Tightness and Slack of Adault Female's Skin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027516
Enrollment
90
Registered
2017-05-28
Start date
2017-05-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A(healthy adults)

Interventions

None listed

Sponsors

Society for Evaluation of the Skin
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: [1]Individuals aged 30-69 years (the rate of smoker and nonsmoker is 1:1). [2]Female who is healthy. [3]Individuals who use 0-2 toner(s) or milky lotion(s) after washing. [4]Individuals whose written informed consent has been obtained.

Exclusion criteria

Exclusion criteria: [1]Individuals whose skin of face has disorder(s), such as atopic dermatitis and hives, or inflammation, eczema, trauma, warts or these mark(s). [2]Individuals who received cosmetic medicine (ex. injection of botox, hyaluronic acid or collagen, or photofacial). [3]Individuals who received special skin care at a beauty salon or an esthetic salon in the past 4 weeks. [4]Individuals who use material(s) constantly except toner(s) or milky lotion(s) such as cream, essence, all-in-one cosmetics. [5]Individuals whose skin is sunburned excessively in the past 4 weeks. [6]Individuals who receive a therapy to treat or prevent disease at the medical organization such as hormone replacement therapy, drug therapy, exercise therapy, or diet remedy, or are judged to receive medical treatment. [7]Individuals who have a history of glucose metabolism, lipid metabolism, hepatopathy, kidney damage, heart disease, cardiovascular disease, respiratory disease, endocrine system disease, or Nervous system disease. [8]Individuals who have a history of alcoholism or drug addiction. [9]Individuals who participated other clinical trials for human subjects with cosmetics, foods, drugs, quasi-drugs, or medical equipment in the past 4 weeks.

Design outcomes

Primary

MeasureTime frame
Indexes for evaluating skin condition (the test day [1 day])

Countries

Japan

Contacts

Public ContactToshiyasu Tamura

TES Holdings Co., Ltd Department of Development for Clinical Trials

t.tamura@tes-h.co.jp03-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026